Sign in to view content

Improvement of Worsening in Diabetic Retinopathy Through 2 Years in a Randomized Trial

Susan B. Bressler, MD, FASRS

Video
Published 2017

Related

PER-001, a Long-acting Endothelin Antagonist Intravitreal Implant, Improved Structure and Visual Function in Patients With Diabetic Retinopathy
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2025
Diabetic Tractional Retinal Detachment Repair and ILM Peel
Rohit Adyanthaya, MD
Innovative Retina Surgical Video Series
2017
Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Andrew J. Barkmeier, MD
Updates from the Field
2024

Category: Diabetic Retinopathy

See more